4,268
Views
8
CrossRef citations to date
0
Altmetric
Drug profile

Levoketoconazole: a novel treatment for endogenous Cushing's syndrome

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 159-174 | Received 12 Feb 2021, Accepted 10 Jun 2021, Published online: 12 Aug 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Marianna Martino, Nairus Aboud, Beatrice Lucchetti, Gianmaria Salvio & Giorgio Arnaldi. (2023) An evaluation of pharmacological options for Cushing’s disease: what are the state-of-the-art options?. Expert Opinion on Pharmacotherapy 24:5, pages 557-576.
Read now

Articles from other publishers (7)

Perrin C. White. 2023. Pediatric Hypertension. Pediatric Hypertension 549 571 .
Maria Fleseriu, Richard J Auchus, Yona Greenman, Sabina Zacharieva, Eliza B Geer, Roberto Salvatori, Rosario Pivonello, Ulla Feldt-Rasmussen, Laurence Kennedy, Michael Buchfelder, Beverly M K Biller, Fredric Cohen & Anthony P Heaney. (2022) Levoketoconazole treatment in endogenous Cushing's syndrome: extended evaluation of clinical, biochemical, and radiologic outcomes. European Journal of Endocrinology 187:6, pages 859-871.
Crossref
Frederic Castinetti. (2022) How best to monitor the specific side effects of medical treatments of Cushing’s disease. Best Practice & Research Clinical Endocrinology & Metabolism 36:6, pages 101718.
Crossref
Maria Fleseriu & Beverly M. K. Biller. (2022) Treatment of Cushing’s syndrome with osilodrostat: practical applications of recent studies with case examples. Pituitary 25:6, pages 795-809.
Crossref
Rosario Pivonello, Sabina Zacharieva, Atanaska Elenkova, Miklós Tóth, Ilan Shimon, Antonio Stigliano, Corin Badiu, Thierry Brue, Carmen Emanuela Georgescu, Stylianos Tsagarakis, Fredric Cohen & Maria Fleseriu. (2022) Levoketoconazole in the treatment of patients with endogenous Cushing’s syndrome: a double-blind, placebo-controlled, randomized withdrawal study (LOGICS). Pituitary 25:6, pages 911-926.
Crossref
Rosario Pivonello, Chiara Simeoli, Nicola Di Paola & Annamaria Colao. (2022) Cushing’s disease: adrenal steroidogenesis inhibitors. Pituitary 25:5, pages 726-732.
Crossref
Perrin C. White. 2020. Pediatric Hypertension. Pediatric Hypertension 1 23 .